Abstract:Objective To investigate the relationship between the polymorphisms of CYP2D6 gene and clinical efficacy of risperidone in schizophrenia.Methods 114 schizophrenia patients were recruited and completed 12 weeks of treatment with risperidone monotherapy.Positive and Negative Syndrome Scale (PANSS),Personal and Social Performance Scale (PSP),Digit Span Test in Wechsler Intelligence Scale,Raven's Standard Progressive Matrices,Digital Cancellation Test were used to assess patients psychotic symptoms and cognitive symptom,and all patients were evaluated at baseline and weekend of 12.178 healthy controls were also collected.Five SNPs (rs1065852,rs1135840,rs16947,rs1080985,rs5030655) in CYP2D6 were genotyped by using TaqMan((R)) SNP Genotyping Assays.SHEsis online software were used to detect the Hardy-Weinberg equilibrium,pairs of polymorphic loci linkage disequilibrium,genotype and allele frequency analysis and haplotype analysis.SPSS17.0 statistical package was used for statistical analysis.Results rs5030655 was found only homozygous,suggesting not polymorphic site.Schizophrenia and control groups were not statistically different in genotype distributions and allele frequencies of four polymorphic sites (P＞0.05).There was a strong linkage disequilibrium between rs16947 and rs1080985 (r2=0.655).Haplotype frequency of three SNPs rs16947/rs1065852/rs1080985 AGG in schizophrenia group was significantly greater than in healthy people (14.26 vs.7.07;x2=8.008,P=0.004).At baseline,CC patients of rs1135840 genotype scored less than CG and GG genotype patients in Raven's Standard Progressive Matrices (F=3.205,P＜0.05),the results still showed statistical significance after Bonferroni corrections (P=0.038).After the treatment of 12 weeks,CC and CG patients of rs1135840 genotype had greater score changes in Raven's Standard Progressive Matrices than patients of the GG genotype (F=3.590,P=0.031),the results still showed statistical significance after Bonferroni corrections (P=0.036,0.038),but there was no significant difference between the scores of genotype CC and genotype CG patients (P＞0.05).After treatment,AA patients of rs16947 genotype had smallest score changes in Digital Cancellation Test(F=3.249,P=0.043),the results still showed statistical significance after Bonferroni corrections (P=0.022,0.042),and there was no statistical significant difference between the genotype GG and AG (P＞0.05).Conclusions There is no relationship between the polymorphism of CYP2D6 gene and the susceptibility of schizophrenia,but rs1135840 may be associated with intellectual impairment at baseline and improvement after treatment in patients with schizophrenia.rs16947 may be associated with improved attention in the treatment of schizophrenia.

Ndt_a_355985 731..736

CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.

Genetic Polymorphism Analysis of the Drug-Metabolizing Enzyme CYP2C9 in a Chinese Tibetan Population.

Systematic polymorphism analysis of the CYP2C9 gene in Chinese Han and Tibetan populations

Genetic Polymorphisms Of The Drug-Metabolizing Enzyme Cytochrome P450 2a6 In A Tibetan Chinese Population

Differences in Genotype and Allele Frequency Distributions of Polymorphic Drug Metabolizing Enzymes CYP2C19 and CYP2D6 in Mainland Chinese Mongolian, Hui and Han Populations

Genetic Analysis of Drug Metabolizing Phase-I Enzymes CYP3A4 in Tibetan Populations.

Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations

Genetic Polymorphisms of Cytochrome P450 2B6 Gene in Han Chinese.

Genetic analysis of drug-metabolizing enzyme CYP 3 A 5 polymorphisms in Tibetans in China

Meta-Analysis of Genome Wide Association Studies Showed Polymorphisms on 2P16.1, 6P22.1 and 10Q24.32 Associated with Schizophrenia in Chinese Han Population

[Polymorphisms of Drug-Metabolizing Enzymes Genes in a Han Chinese Population].

Allele and Genotype Frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 Gene Polymorphisms among Mainland Tibetan, Mongolian, Uyghur, and Han Chinese Populations.

Genetic variations of human CYP2D6 in the Chinese Han population.

Systematic Polymorphism Analysis of the CYP2D6 Gene in Four Different Geographical Han Populations in Mainland China.

Genetic Polymorphism Analysis of Cytochrome P4502E1 (CYP2E1) in a Chinese Tibetan Population.

Genetic Polymorphisms of the Drug-Metabolizing Enzyme CYP2J2 in a Tibetan Population

Investigation of the Major Cytochrome P450 1a2 Genetic Variant in A Healthy Tibetan Population in China

The correlation between CYP2D6 gene polymorphisms and clinical response of risperidone treatment in Chinese Han schizophrenia patients